QA: Endocyte INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001235007_2016_Endocyte_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001235007, Endocyte INC

  xvar xval
0 AssetsCurrent 174,875,574
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,398,398
3 remainder_Assets 111,605
4 LiabilitiesCurrent 6,188,993
5 LiabilitiesNoncurrent 18,503
6 remainder_Liabilities 831,944
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,007,709
9 ResearchAndDevelopmentExpense 27,891,604
10 remainder_Expenses 0
11 remainder_Revenues 511,708
12 remainder_NetIncome 2,369,836
13 remainder_ComprehensiveNetIncome -200,093
  yvar yval
0 Assets 178,385,577
1 Liabilities 7,039,440
2 Expenses 43,899,313
3 Revenues 511,708
4 StockholdersEquity 171,346,137
5 NetIncome -41,017,769
6 ComprehensiveNetIncome -41,117,816
7 BaseVar 116,202,984
8 EconomicCapitalRatiobeforeLimitedLiability 3.59
9 EconomicCapitalRatio 4.09

Edgar->Model Mapping

Feature Distribution

Change over Time